Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared
- PMID: 2445507
Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared
Abstract
We did a comparative analysis of the physiological and analytical properties of prostate-specific antigen (PSA), acid phosphatase (ACP; EC 3.1.32) activity, and acid phosphatase antigen (PAP) in serum. The PSA assay is sensitive to 0.2 microgram/L and demonstrates good linearity (y = 1.01x + 0.74). The CV was 3.9% at 40 micrograms/L, 8.0% at 3.1 micrograms/L. PSA and PAP are less stable at 4 degrees C than at -20 degrees C. Serum PAP and ACP concentrations showed large intra-individual fluctuations (average CVs of 22% and 24%, respectively), which were not observed with PSA measurements (average CV 6.2%). We saw significant correlation with the magnitude of physiological change when analytes were compared for serially collected split samples [y(PSA) = 0.14x(PAP) + 0.00, r = 0.767], which indicates that a common factor is influencing this variation. The excellent analytical performance, tissue specificity, and small degree of intra-individual variance are characteristics that favor the measurement of PSA in serum for monitoring patients with prostatic cancer.
Similar articles
-
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.Clin Chem. 1987 Dec;33(12):2257-61. Clin Chem. 1987. PMID: 2446807
-
A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.Clin Chim Acta. 1988 May 31;174(2):131-40. doi: 10.1016/0009-8981(88)90380-4. Clin Chim Acta. 1988. PMID: 2454767
-
[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].Ned Tijdschr Geneeskd. 1990 Aug 18;134(33):1596-600. Ned Tijdschr Geneeskd. 1990. PMID: 1697651 Dutch.
-
Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.Eur J Surg Oncol. 1990 Feb;16(1):37-41. Eur J Surg Oncol. 1990. PMID: 1689677 Review.
-
Tumor markers in prostate cancer.Cancer. 1992 Jul 1;70(1 Suppl):225-9. doi: 10.1002/1097-0142(19920701)70:1+<225::aid-cncr2820701309>3.0.co;2-v. Cancer. 1992. PMID: 1376192 Review.
Cited by
-
Daily variability of serum prostate-specific antigen in men over 50 years of age.Int Urol Nephrol. 2001;33(4):641-4. doi: 10.1023/a:1020583203777. Int Urol Nephrol. 2001. PMID: 12452618
-
Morphologic and regulatory aspects of prostatic function.Anat Embryol (Berl). 1989;179(6):519-31. doi: 10.1007/BF00315695. Anat Embryol (Berl). 1989. PMID: 2665570 Review.
-
Prostate-specific antigen kallikrein and the heart.World J Cardiol. 2009 Dec 31;1(1):23-5. doi: 10.4330/wjc.v1.i1.23. World J Cardiol. 2009. PMID: 21160572 Free PMC article.
-
Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen.World J Urol. 1993;11(4):218-20. doi: 10.1007/BF00185073. World J Urol. 1993. PMID: 7508787
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous